<DOC>
	<DOCNO>NCT00320892</DOCNO>
	<brief_summary>Dying patient often unable clear secretion large airway , result noisy breathe usually describe `` death rattle . '' While evidence patient find condition disturbing , noise may disturb patient 's visitor caregiver may fear patient choke death . In Israel none pharmaceutical drug list literature exist . Thus , Atropine drop noted literature use , though accord knowledge evidence clinical trial use sublingual Atropine conduct . The study design randomly control , double blind crossover trial . The patient serve control , crossover placebo drug ( randomly choose ) take place . The administrator drug blind medication , time randomly begin different drug ( placebo Atropine ) . We evaluate Atropine Sulphate 1 % ophthalmic drop effect 33 patient use noise score scale 0-3 . Noise score take start ; 30 min drug/placebo administration every hour thereafter . After 4-hours crossover take place evaluation follow protocol .</brief_summary>
	<brief_title>`` Death Rattle '' - A Double Blind , Randomly Controlled , Crossover Trial</brief_title>
	<detailed_description />
	<mesh_term>Death</mesh_term>
	<mesh_term>Atropine</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>: Patients belong Home Palliative Care Unit Clalit Health Services Southern District , Oncology Department Soroka University Medical Center suffer `` death rattle '' recruit study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Death Rattle</keyword>
	<keyword>Noise level</keyword>
	<keyword>Primary Care</keyword>
</DOC>